In a new patent number, 20190365286, Apple describes a new disease diagnosis feature for the Apple Watch. Apple is working on the use of new sensors in the Apple Watch to continuously monitor motion disorders and tremors, which could help clinicians better treat Parkinson’s disease.
In patent documents, Apple says Parkinson’s disease is a movement disorder, an uncontrollable involuntary movement that resembles convulsions, fidgeting, swinging or swinging. The quality of life of the patient depends to a large extent on the accuracy of the clinician’s diagnosis and arrangement of medication to minimize the patient’s symptoms.
The Apple Watch patent uses motion sensors to monitor movements and uses the Unified Parkinson’s Disease Score Scale (UPDRS) to analyze data on devices.
Apple says this provides a number of benefits and benefits for patients and clinicians, including a full-day symptom/severity tracking information and a clinical tool to assess patients’ responses to the drug.
Most patients report their problems themselves, and clinicians work on what they tell them and the range of tests they can perform.
However, Apple says self-reporting is unreliable and can only be tested if the patient is at the clinic. As a result, Apple has proposed using wearable computing devices to track motion disorders and tremor symptoms, allowing doctors to use medication more precisely based on their condition.